Trinity Biotech plc
TRIB
$0.34
$0.000.00%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 8.31% | -0.01% | -34.69% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 8.31% | -0.01% | -34.69% |
| Cost of Revenue | -- | -- | 7.31% | -2.25% | -17.45% |
| Gross Profit | -- | -- | 10.24% | 4.31% | -56.83% |
| SG&A Expenses | -- | -- | -7.50% | -19.22% | -10.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | 1,367.38% | 91.29% | 6,788.64% |
| Total Operating Expenses | -- | -- | 3.42% | -9.35% | -12.38% |
| Operating Income | -- | -- | 14.03% | 40.77% | -166.30% |
| Income Before Tax | -- | -- | 16.78% | 51.18% | -363.07% |
| Income Tax Expenses | -- | -- | 923.73% | -47.83% | -764.56% |
| Earnings from Continuing Operations | -- | -- | 15.33% | 51.34% | -354.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -100.02% | 6,334.48% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -32.35% | 28.89% | -308.36% |
| EBIT | -- | -- | 14.03% | 40.77% | -166.30% |
| EBITDA | -- | -- | 8.03% | 45.57% | -150.64% |
| EPS Basic | -- | -- | 43.67% | 38.90% | -186.53% |
| Normalized Basic EPS | -- | -- | 47.17% | 47.17% | -222.50% |
| EPS Diluted | -- | -- | 36.13% | 38.09% | -180.64% |
| Normalized Diluted EPS | -- | -- | 47.17% | 47.17% | -222.50% |
| Average Basic Shares Outstanding | -- | -- | 52.52% | 22.49% | 40.58% |
| Average Diluted Shares Outstanding | -- | -- | 52.53% | 22.49% | 36.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |